Elephas Information

Elephas is a global leader in functional precision medicine. Our elive™ platform is a breakthrough live‑tissue technology designed to measure therapeutic response across oncology treatment. Cancer is a leading cause of death worldwide, with the number of patients projected to triple by 2060. Despite a significant increase in the number of available immunotherapies and targeted therapies, only a fraction of patients receiving these treatments obtain a response, and many who may respond are not eligible for therapy due to a lack of accurate predictive biomarkers. With the mission to tackle this growing dilemma, Elephas has developed an ex vivo platform to assess how live tumor tissue responds to oncology therapies. By preserving the native tumor microenvironment from a live core needle biopsy and using a novel method to address tumor heterogeneity, the elive™ platform provides a functional readout, offering valuable insight for treatment decisions.